Abbvie Inc Stock Filter Stocks by Fundamentals
ABBV Stock | USD 167.89 1.48 0.89% |
AbbVie Inc fundamentals help investors to digest information that contributes to AbbVie's financial success or failures. It also enables traders to predict the movement of AbbVie Stock. The fundamental analysis module provides a way to measure AbbVie's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AbbVie stock.
Last Reported | Projected for Next Year | ||
Debt To Equity | 5.73 | 4.39 |
AbbVie | Debt to Equity |
Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
All Next | Launch Module |
AbbVie ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, AbbVie's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to AbbVie's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
AbbVie Fundamentals
Return On Equity | 0.35 | ||||
Return On Asset | 0.0807 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.32 % | ||||
Current Valuation | 341.76 B | ||||
Shares Outstanding | 1.77 B | ||||
Shares Owned By Insiders | 0.10 % | ||||
Shares Owned By Institutions | 71.95 % | ||||
Number Of Shares Shorted | 13.12 M | ||||
Price To Earning | 21.28 X | ||||
Price To Book | 27.74 X | ||||
Price To Sales | 5.29 X | ||||
Revenue | 54.32 B | ||||
Gross Profit | 41.53 B | ||||
EBITDA | 18.1 B | ||||
Net Income | 4.88 B | ||||
Cash And Equivalents | 11.88 B | ||||
Cash Per Share | 6.72 X | ||||
Total Debt | 59.38 B | ||||
Debt To Equity | 4.37 % | ||||
Current Ratio | 0.93 X | ||||
Book Value Per Share | 5.87 X | ||||
Cash Flow From Operations | 22.84 B | ||||
Short Ratio | 2.04 X | ||||
Earnings Per Share | 2.71 X | ||||
Price To Earnings To Growth | 0.45 X | ||||
Target Price | 184.49 | ||||
Number Of Employees | 50 K | ||||
Beta | 0.56 | ||||
Market Capitalization | 294.65 B | ||||
Total Asset | 134.71 B | ||||
Retained Earnings | (1000 M) | ||||
Working Capital | (4.84 B) | ||||
Current Asset | 16.31 B | ||||
Current Liabilities | 10.89 B | ||||
Annual Yield | 0.04 % | ||||
Five Year Return | 4.33 % | ||||
Net Asset | 134.71 B | ||||
Last Dividend Paid | 5.99 |
About AbbVie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AbbVie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with AbbVie
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.Moving against AbbVie Stock
0.48 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AbbVie Piotroski F Score and AbbVie Altman Z Score analysis. Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Transaction History View history of all your transactions and understand their impact on performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.67) | Dividend Share 5.99 | Earnings Share 2.71 | Revenue Per Share 30.723 | Quarterly Revenue Growth (0.05) |
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.